Research on the dissemination mechanism of Mycobacteroides abscessus through ferroptosis and development of host-directed immune therapy
Year: 2023
Type: dissertation
Abstract: Mycobacteroides abscessus (M. abscessus) is most common nontuberculous mycobacterial species causing infectious disease in humans. Unfortunately, it is notoriously challenging to treat due to its intrinsic or acquired resistance to first-line anti-TB drugs as well as to most antibiotics commonly used for treatment. The rough morphotype (MaRg) of M. abscessus, which is distinguished from the smooth morphotype (MaSm) by the absence of cell surface glycopeptidolipids (GPLs), is linked to more severe and persistent infection than MaSm. However, the precise virulence mechanisms of MaRg and its relationship with virulence factors are currently unclear. In this study, the role of ferroptosis in M. abscessus infection, specifically in the dissemination of MaRg, is investigated. The study suggests that the external cell wall lipid MaRg, phosphatidyl-myo-inositol mannoside-Franction 7 (PIM-F7) promotes MaRg pathogenicity and propagation by inducing ferroptosis, providing novel insights into the virulence mechanisms of M. abscessus. Mechanistically, PIM-F7 is shown to interact with mitochondrial ROS production through TLR2-dependent iron accumulation, which promotes MaRg pathogenicity and dissemination by activating lipid peroxidation and inducing ferroptosis. Overall, these findings shed light on the molecular mechanisms of pathogen-induced ferroptosis and suggest potential therapies targeting iron accumulation-dependent ferroptosis by disrupting M. abscessus-host interactions (Chapter 1). This study demonstrates a strong interaction between increasing cellular metabolism and innate macrophage immunity and shows that Mycobacteroides massiliense (M. massiliense) intracellular replication in macrophages dependents on host pyruvate dehydrogenase kinase (PDK) activity. M. massiliense infection triggers a metabolic shift in macrophages, leading to an increase in glycolysis and a decrease in oxidative phosphorylation. However, treatment with the PDK inhibitor dichloroacetate (DCA) reverses this metabolic shift in infected macrophages and restrict intracellular replication. \nMechanistically, DCA activates AMPKα1 by increasing the AMP/ATP ratio, thereby inducing autophagy and limiting bacterial proliferation in phagosomes. These results suggests that pharmacologic inhibition of PDK may represent a promising strategy for host-directed therapy aimed at controlling M. massiliense infections (Chapter 2).
Author: 전해련
Institution: Seoul National University
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7024601747
